Stay updated on Avelumab Program Rollover Study Clinical Trial

Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Program Rollover Study Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.3, indicating a software/template version update. This update is a backend version bump and does not modify the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-30T17:36:46.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label changed from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:49:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Padua, Italy has been changed to Padova, Italy in the Locations section.
    Difference
    0.0%
    Check dated 2026-04-09T08:30:18.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Key study timeline fields were updated to reflect revised primary and study completion dates.
    Difference
    0.2%
    Check dated 2026-04-02T04:46:45.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Napoli, Italy was removed and Naples, Italy was added to the list of study locations. The update aligns the location naming with English usage for easier recognition.
    Difference
    0.0%
    Check dated 2026-03-25T21:28:45.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The revision tag was updated to v3.5.0 and the previous tag v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:08.000Z thumbnail image

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.